KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Times Interest Earned (2016 - 2025)

Historic Times Interest Earned for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $5.03.

  • Emergent BioSolutions' Times Interest Earned fell 3523.56% to $5.03 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.99, marking a year-over-year increase of 20867.59%. This contributed to the annual value of -$1.53 for FY2024, which is 8147.39% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Times Interest Earned of $5.03 as of Q3 2025, which was down 3523.56% from $0.11 recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Times Interest Earned registered a high of $31.87 during Q4 2021, and its lowest value of -$12.29 during Q3 2023.
  • In the last 5 years, Emergent BioSolutions' Times Interest Earned had a median value of -$0.64 in 2024 and averaged -$0.24.
  • In the last 5 years, Emergent BioSolutions' Times Interest Earned skyrocketed by 90417.85% in 2021 and then tumbled by 128486.82% in 2022.
  • Over the past 5 years, Emergent BioSolutions' Times Interest Earned (Quarter) stood at $31.87 in 2021, then plummeted by 113.56% to -$4.32 in 2022, then soared by 53.28% to -$2.02 in 2023, then skyrocketed by 68.2% to -$0.64 in 2024, then skyrocketed by 884.07% to $5.03 in 2025.
  • Its last three reported values are $5.03 in Q3 2025, $0.11 for Q2 2025, and $3.39 during Q1 2025.